Home > Boards > US OTC > Biotechs >

Aequus Pharmaceuticals (AQSZF)

Add AQSZF Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 11/9/2018 8:59:36 PM - Followers: 19 - Board type: Free - Posts Today: 0


Update April 8, 2017
Aequus Pharma (AQS.V) (AQSZF)

Market-Cap: c$17 Million (US$12 Million)
Cash: c$5.1 Million << enough untill mid 2018
Price: $0.17

Shares out: 71 Million

>>>>>>NEW interview with Ceo // May, 2017<<<<<<


MUST WATCH to realize the mega potential here

Lots of new Product in-licensing on the way to drive this unknown gem to profitability quickly ( see chart below ):

AQSZF (MC US$ 15M) 2 Marketed Drugs + 3 close to Approval including a Potential Blockbuster = SUPER LIFETIME OPPORTUNITY -

This undiscovered low float rocket is definitely the cheapest Biotech Gem you can get at this time. This Stock has 10 bagger Potential easily with all the Big Drugs close to Market entry .Get some of this Goldmine before she gets discovered .Management alone holding over 16 Million shares Ceo bought 840k shares at 0.30 just a few days ago .GLTA

Presentation November 2016



AQS1301 topline results in 1Q

File for CDN approval of Topiramate XR in 1H 2017

File for CDN approval of Oxcarbazepine XR in 1H 2017

Additional Product acquisitions in 2017

Partnership for AQS1301 in 2017

Operational profitability estimated in 2017

Two products launches to date (Tacrolimus IR and Vistitan™)

3 long-acting, transdermal programs in development, on track to file NDA in 2018

Marketed Products:

Tacrolimus IR : Aequus initiated promotional efforts for tacrolimus IR in December, 2015 •Tacrolimus products currently account for ~30% of a $300 million immunosuppressive market in Canada •Aequus is promoting the first to market generic version of Prograf (tacrolimus IR)

Vistitan : Aequus initiated commercial activities in Q2 2016 for Vistitan (bimatoprost 0.03%) •The Canadian glaucoma market in 2014 was estimated to be over $137 million, of which prostaglandins remain one of the primary treatment options.

NDA Filing for AQS-1301:Expected 3Q2017 Expected Commercial License (If Bioequivalence demonstrated in Phase I, Registration Study may NOT be required for Approval of AQS1301)

AQS-1301, a transdermal aripiprazole product candidate in development for potential weekly use in the treatment of irritability associated with autistic disorder, bipolar I disorder, schizophrenia and major depressive disorder. The currently available dosage forms of aripiprazole (sold primarily under the trade name Abilify®) reached total worldwide sales of over $8 billion USD in 2014. A once-weekly transdermal patch has the potential to improve medication adherence and reduce the frequency of relapse.

Podcast: Aequus Pharmaceuticals CEO Doug Janzen on the low cost of drug commercialization in Canada


James West: Sure. Have you built a pharmaceutical company before, Doug?

Doug Janzen: I have. So I’ve been in this industry for 20 years. I was a banker, then I ran a therapeutic company called Cardiome Pharma; I built that from 50 million to over 1 billion at its peak, and exited after doing an $800 million license with Merck — still the largest license transaction in Canadian history.

James West: Sure. Let me ask that another way: how do you plan to get to – I mean, how many of these deals can you do a year?

Doug Janzen: We bought our commercial infrastructure last July, and since then we’ve launched two products and we’ve just licensed the two Supernus programs. Those four products, we think an aggregate can do $40 million, $45 million at peak sales.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#215   I agree!! Basil22 11/09/18 08:59:36 PM
#214   I am still here.. Chaka 11/09/18 04:48:11 AM
#213   Smart company move to create an advisory board for Basil22 11/05/18 09:07:03 AM
#212   Great interview supports why they have a great Basil22 10/22/18 10:17:49 PM
#211   Fully agree. GLTA GW greenwillow 09/04/18 01:20:56 PM
#210   Awesome company led by a smart CEO with Basil22 09/03/18 07:03:11 PM
#209   Aequus Reports 5th Consecutive Quarter of Revenue Growth molee 08/27/18 08:51:31 AM
#208   Aequus Announces Expansion of Market Opportunity for its molee 07/19/18 09:49:18 AM
#207   Aequus and Corium Join Forces to Advance Anti-Nausea molee 06/21/18 09:23:29 AM
#206   Aequus Announces First Canadian Cataract Procedures Using Zepto molee 06/18/18 09:06:27 AM
#205   Aequus Provides First Quarter 2018 Financial and Corporate Highlights molee 05/31/18 10:09:13 AM
#203   How big of a market for this product? Chaka 05/17/18 04:11:50 AM
#202   Aequus Announces Official Launch of Zepto Capsulotomy System molee 05/16/18 09:45:10 AM
#201   Sell the news again ? Can't seem to molee 05/04/18 10:07:17 AM
#200   SUPER NEWS!!! notshakenorstirred 05/03/18 06:11:44 PM
#199   Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch molee 05/03/18 10:05:30 AM
#198   Super news, for the soon to explode, Canadian notshakenorstirred 04/27/18 07:05:23 PM
#197   No problem! Chaka 03/21/18 04:08:11 AM
#196   Great article, Chaka, thanks for posting! notshakenorstirred 03/19/18 09:11:05 PM
#195   NEWS OUT! Chaka 03/19/18 08:52:42 AM
#194   In time this "fledgling" will take flight.....and soar!!! notshakenorstirred 03/17/18 07:43:37 PM
#193   WOW! GIGANTIC ARTICLE INDEED! Chaka 03/14/18 03:31:17 AM
#192   A must Read! The Biggest Biotech Trends Analysts notshakenorstirred 03/13/18 05:33:44 PM
#190   $AQSZF on the move again ...... molee 02/16/18 10:53:30 AM
#189   Taking a bit of a bath here as molee 02/02/18 02:40:22 PM
#188   Aequus and Camargo Prepare for Meeting with FDA molee 01/31/18 09:33:27 AM
#187   CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to molee 01/11/18 07:48:31 AM
#186   Coulda shoulda woulda. Thought about this a chainma1l 01/03/18 10:13:45 AM
#185   watch this bad boy run!! TrendTrade2016 01/03/18 06:08:59 AM
#184   NO NEWS & UP THIS MUCH? Chaka 01/03/18 12:07:27 AM
#183   Dilly Dilly ... ;-) molee 01/02/18 02:17:19 PM
#182   WOW. Chaka 01/02/18 02:01:14 PM
#181   .25 now , on a roll ..... ;-) molee 01/02/18 11:09:48 AM
#180   Ton of insider buying lately ... $AQSZF molee 01/02/18 07:51:54 AM
#179   Looking much better here ... Will it last ??? molee 12/05/17 08:59:57 AM
#178   Management Discussion and Analysis : molee 11/30/17 01:38:45 AM
#177   Interim Financial Report : molee 11/30/17 01:37:48 AM
#176   Sell some product , willya ??? molee 11/17/17 09:46:49 AM
#175   Aequus Granted European Patent for Once-Weekly Transdermal Aripiprazole molee 11/16/17 10:18:28 AM
#174   Aequus Granted Chinese Patent for Once-Weekly Transdermal Aripiprazole molee 10/10/17 09:42:21 AM
#173   Some pre-market strength this morning . molee 09/21/17 09:21:02 AM
#172   Sell the news ?? WTF ? molee 09/08/17 11:49:22 AM
#171   This stock is perfect for LONG INVESTOR'S that Chaka 09/07/17 04:47:53 PM
#170   Aequus Announces Positive Results for Proof of Concept molee 09/07/17 02:35:16 PM
#169   Aequus Provides Second Quarter 2017 Operational Highlights molee 08/30/17 01:44:34 AM
#168   Aequus and Ehave Collaborate on Bioinformatics Platform for molee 08/28/17 11:31:36 AM
#167   Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole[/b molee 08/24/17 10:19:18 AM
#166   SP isn't looking so good lately ... ;-( molee 08/21/17 10:16:17 AM
#165   Does anybody have any info relating to the toddski 08/20/17 09:57:33 PM
#164   Aequus and Scientus Agree to Terms for a molee 08/01/17 11:04:45 AM